These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22102888)

  • 21. Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.
    Furuhashi M; Hiramitsu S; Mita T; Omori A; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Matsumoto M; Tanaka M; Moniwa N; Yoshida H; Ishii J; Miura T
    Lipids Health Dis; 2016 Jan; 15():5. PubMed ID: 26754658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aortic pulse wave velocity index and mortality in end-stage renal disease.
    Blacher J; Safar ME; Guerin AP; Pannier B; Marchais SJ; London GM
    Kidney Int; 2003 May; 63(5):1852-60. PubMed ID: 12675863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin and cardiovascular outcomes among hemodialysis patients.
    Abdallah E; Waked E; Nabil M; El-Bendary O
    Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the Role of FABP4 in Diabetes and Obesity and the Influence of Age and Ethnicity: A Comprehensive Analysis of a Cohort from the KEDP-Study.
    Abdalla MA; Abubaker J; Abu-Farha M; Al-Khairi I; Cherian P; Qaddoumi MG; Al-Rashed F; Thanaraj TA; Albatineh AN; Al-Mulla F
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Fatty Acid Binding Protein 4 (FABP4) in Kidney Disease.
    Shi M; Ma L; Fu P
    Curr Med Chem; 2020; 27(22):3657-3664. PubMed ID: 30306857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
    Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
    Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.
    Park WY; Koh ES; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    PLoS One; 2015; 10(9):e0138159. PubMed ID: 26376075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients.
    Masuda T; Murata M; Honma S; Iwazu Y; Sasaki N; Ogura M; Onishi A; Ando Y; Muto S; Shimada K; Kario K; Kusano E; Asano Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2289-95. PubMed ID: 21220756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.
    Matsui K; Kamijo-Ikemori A; Imai N; Sugaya T; Yasuda T; Tatsunami S; Toyama T; Shimizu M; Furuichi K; Wada T; Shibagaki Y; Kimura K
    Clin Exp Nephrol; 2016 Apr; 20(2):195-203. PubMed ID: 26189083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients.
    Hogas S; Schiller A; Voroneanu L; Constantinescu D; Timar R; Cianga P; Siriopol D; Bob F; Cianga C; Onofriescu M; Gadalean F; Hogas M; Mihaescu A; Bilha SC; Timar B; Kanbay M; Banach M; Covic A
    Angiology; 2016 Oct; 67(9):854-9. PubMed ID: 26787685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
    Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients.
    Takahashi H; Ito Y; Ishii H; Aoyama T; Kamoi D; Kasuga H; Yasuda K; Maruyama S; Matsuo S; Murohara T; Yuzawa Y
    J Cardiol; 2014 Jul; 64(1):32-6. PubMed ID: 24365385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.
    Hsu BG; Chen YC; Lee RP; Lee CC; Lee CJ; Wang JH
    Circ J; 2010 Feb; 74(2):327-31. PubMed ID: 20009357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between serum adipocyte fatty acid-binding protein and 3-month disability outcome after aneurysmal subarachnoid hemorrhage.
    Luo YG; Han B; Sun TW; Liu X; Liu J; Zhang J
    J Neuroinflammation; 2020 Feb; 17(1):66. PubMed ID: 32075656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension.
    Furuhashi M; Mita T; Moniwa N; Hoshina K; Ishimura S; Fuseya T; Watanabe Y; Yoshida H; Shimamoto K; Miura T
    Hypertens Res; 2015 Apr; 38(4):252-9. PubMed ID: 25672659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.
    Tanaka M; Ishii H; Aoyama T; Takahashi H; Toriyama T; Kasuga H; Takeshita K; Yoshikawa D; Amano T; Murohara T
    Atherosclerosis; 2011 Dec; 219(2):643-7. PubMed ID: 22018643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.
    Okazaki Y; Furuhashi M; Tanaka M; Mita T; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    PLoS One; 2014; 9(12):e115429. PubMed ID: 25506691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.
    Furuhashi M; Ogura M; Matsumoto M; Yuda S; Muranaka A; Kawamukai M; Omori A; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Harada-Shiba M; Shimamoto K; Miura T
    Sci Rep; 2017 Mar; 7(1):217. PubMed ID: 28303004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.